Page 29 - Read Online

Page 16 of 16 Chen et al. Hepatoma Res 2018;4:72 I http://dx.doi.org/10.20517/2394-5079.2018.103

70. Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, et al. Factors that affect risk for hepatocellular carcinoma and effects of
surveillance. Clin Gastroenterol Hepatol 2011;9:617-23.
71. Kuo YH, Lu SN, Chen CL, Cheng YF, Lin CY, et al. Hepatocellular carcinoma surveillance and appropriate treatment options improve
survival for patients with liver cirrhosis. Eur J Cancer 2010;46:744-51.
72. Pascual S, Irurzun J, Zapater P, Such J, Sempere L, et al. Usefulness of surveillance programmes for early diagnosis of hepatocellular
carcinoma in clinical practice. Liver Int 2008;28:682-9.
73. Tanaka H, Nouso K, Kobashi H, Kobayashi Y, Nakamura S, et al. Surveillance of hepatocellular carcinoma in patients with hepatitis C virus
infection may improve patient survival. Liver Int 2006;26:543-51.
74. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, et al. Impact of surveillance on survival of patients with initial hepatocellular
carcinoma: a study from Japan. Clin Gastroenterol Hepatol 2006;4:1170-6.
75. Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, et al. Surveillance program for early detection of hepatocellular carcinoma in
Japan: results of specialized department of liver disease. J Clin Gastroenterol 2006;40:942-8.
76. Chen THH, Chen CJ, Yen MF, Lu SN, Sun CA, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a
high risk group in Taiwan. Int J Cancer 2002;98:257-61.